GLP-1 Race Heats Up with Positive Test Results for Next-Gen Eli Lilly Drug Approximately one in eight Americans are taking medications like Ozempic or Wegovy for weight loss, diabetes, heart disease and more
One study has indicated that after 16 weeks of treatment, on average, people lose 5.7% of their body weight and a separate study has shown that after a period of 68 weeks, there is an average of 15% of body weight lost
However, PEGylation reduces the affinity for the receptor somewhat
The company also introduced single-dose Zepbound vials as a lower-cost packaging option
Nutrition quality should be prioritized over restriction, especially in patients using GLP-1 therapies
Not in replacing human judgment, but in restoring it by giving professionals better inputs to think with #Lean I also wonder how many organizations are sitting on similar hidden datasets, pages of Excel sheets filled with free text such as customer complaints, control gaps, or performance review notes